Items where authors include "Coleman, R"

Article

Winter, M, Coleman, R, Kendall, J orcid.org/0000-0003-2884-4849 et al. (13 more authors) (2022) A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results. Journal of Bone Oncology, 35. 100442. ISSN 2212-1374

Vogt, KS, Grange, A, Johnson, J orcid.org/0000-0003-0431-013X et al. (4 more authors) (2022) Study protocol for the online adaptation and evaluation of the ‘Reboot’ (Recovery-boosting) coaching programme, to prepare critical care nurses for, and aid recovery after, stressful clinical events. Pilot and Feasibility Studies, 8 (1). 63. ISSN 2055-5784

Coleman, R, Brown, J, Rathbone, E et al. (9 more authors) (2020) CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial. Trials, 21. 89. ISSN 1745-6215

Gray, R, Bradley, R, Braybrooke, J et al. (164 more authors) (2019) Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet, 393 (10179). pp. 1440-1452. ISSN 0140-6736

Wilson, C, Bell, R, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (5 more authors) (2018) Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. European Journal of Cancer, 94. pp. 70-78. ISSN 0959-8049

Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Asselain, B, Barlow, W, Bartlett, J et al. (107 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Coleman, R, Hall, A, Albanell, J et al. (10 more authors) (2017) Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial. The Lancet Oncology, 18 (11). pp. 1543-1552. ISSN 1470-2045

Morden, JP, Alvarez, I, Bertelli, G et al. (18 more authors) (2017) Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology, 35 (22). pp. 2507-2514. ISSN 0732-183X

Cameron, D, Morden, JP, Canney, P et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

Baird, R, Banks, I, Cameron, D et al. (53 more authors) (2016) An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. 608.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Coleman, R, Powles, T et al. (102 more authors) (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet, 386 (10001). 1353 - 1361. ISSN 0140-6736

Coleman, R, Cameron, D, Dodwell, D et al. (13 more authors) (2014) Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology, 15 (9). 997 - 1006. ISSN 1470-2045

Coleman, R, Hinsley, S orcid.org/0000-0001-6903-4688, Bell, R et al. (7 more authors) (2013) Adjuvant therapy in early breast cancer with zoledronic acid (AZURE - BIG 01/04): Final efficacy analysis. European Journal of Cancer, 49 (Suppl 3). S5-S5. ISSN 0959-8049

Coleman, R, Woodward, E, Brown, J et al. (11 more authors) (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment, 127 (2). 429 - 438. ISSN 1573-7217

Dodwell, D, Thorpe, H and Coleman, R (2009) Refining systemic therapy for early breast cancer: difficulties with subtraction. The Lancet Oncology, 10 (8). 738 - 739. ISSN 1470-2045

Conference or Workshop Item

Winter, M, Kendall, J, Brown, S orcid.org/0000-0002-7975-7537 et al. (9 more authors) (2021) PS14-02: A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas, USA.